The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Zinc Oxide Nanoparticles Show Antidiabetic Activity in Streptozotocin-Induced Type 1 and 2 Diabetic Rats
Abstract
AIM: The correlation of diabetes and an imbalance in zinc homeostasis makes zinc-based therapy an attractive proposition. In this study, zinc oxide nanoparticles were evaluated for antidiabetic effects and safety. MATERIALS & METHODS: Zinc oxide nanoparticles (1, 3 and 10 mg/kg) were tested for antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats. A single-dose pharmacokinetic study, cytotoxicity, hemolysis, acute and subacute toxicity tests, and mechanism-of-action studies were performed. RESULTS: Oral administration of zinc oxide nanoparticles resulted in significant antidiabetic effects--that is, improved glucose tolerance, higher serum insulin (70%), reduced blood glucose (29%), reduced nonesterified fatty acids (40%) and reduced triglycerides (48%). Nanoparticles were systemically absorbed resulting in elevated zinc levels in the liver, adipose tissue and pancreas. Increased insulin secretion and superoxide dismutase activity were also seen in rat insulinoma (RIN-5F) cells. Nanoparticles were safe up to a 300 mg/kg dose in rats. CONCLUSION: Zinc oxide nanoparticles are a promising antidiabetic agent warranting further studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
Cited by
The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications
Jiang, J., Pi, J., & Cai, J. (2018) · Bioinorganic Chemistry and Applications · doi:10.1155/2018/1062562 · Cited by 1,255
ZnO nanostructured materials and their potential applications: progress, challenges and perspectives
Raha, S., & Ahmaruzzaman, M. (2022) · Nanoscale Advances · doi:10.1039/d1na00880c · Cited by 1,107
A Mini Review of Antibacterial Properties of ZnO Nanoparticles
Gudkov, S. V., Burmistrov, D. E., Serov, D. A., Rebezov, M. B., Semenova, A. A., & Lisitsyn, A. B. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.641481 · Cited by 589
Synthesis, optimization and applications of ZnO/polymer nanocomposites
Ponnamma, D., Cabibihan, J.-J., Rajan, M., Pethaiah, S. S., Deshmukh, K., Gogoi, J. P., Pasha, S. K. K., Ahamed, M. B., Krishnegowda, J., Chandrashekar, B. N., et al. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.081 · Cited by 304
Singh, T. A., Sharma, A., Tejwan, N., Ghosh, N., Das, J., & Sil, P. C. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102495 · Cited by 283
Metadata
- Authors
- Umrani, R. D., & Paknikar, K. M.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2013-12-19
- Volume
- 9
- Issue
- 1
- Pages
- 89-104
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2156933665
- Cited by
- 222
- References
- 1
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zinc Oxide Nanoparticles Show Antidiabetic Activity in Streptozotocin-Induced Type 1 and 2 Diabetic Rats. https://app.cochat.ai/papers/10.2217/nnm.12.205
- The paper
- Umrani, R. D., & Paknikar, K. M. (2014). Zinc Oxide Nanoparticles Show Antidiabetic Activity in Streptozotocin-Induced Type 1 and 2 Diabetic Rats. Nanomedicine. https://doi.org/10.2217/nnm.12.205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.